NCCN 2014 Congress Series: Melanoma - Advanced Melanoma: New Developments and Challenges of Novel Therapies

August 26, 2014

This educational webinar series is designed to addresses the health care professionals' need to be educated on current and emerging evidence-based scientific data for accurate and timely clinical evaluation of patients with melanoma and related skin cancers, management of both early-stage and late-stage diseases and advanced cancer.

Target Audience

This educational activity is designed to meet the educational needs of oncologists, nurses, pharmacists, dermatologists and other healthcare professionals who manage patients with melanoma and related skin cancers.

Learning Objectives

Following this activity, participants should be able to:

  • Explain the difference between immunotherapy and targeted therapy as it relates to  advanced melanoma
  • Describe the unique toxicity profiles and surveillance necessary for recently-approved agents in targeting advanced melanoma
Additional information
Supporters: 

This activity is supported by educational grants from: 

  • Bristol-Myers Squibb
  • Genentech
  • Merck Sharp & Dohme Corp.
Course summary
Available credit: 
  • 1.00 Participation
  • 1.00 Nurse
  • 1.00 Pharmacist
  • 1.00 Physician
Course opens: 
08/25/2014
Course expires: 
10/21/2014
Event starts: 
08/26/2014 - 1:00pm EDT
Event ends: 
08/26/2014 - 2:00pm EDT
Cost:
$0.00
Add to calendar: 

Gregory A. Daniels, MD, PhD
UC San Diego Moores Cancer Center

This activity is approved for AMA PRA Category 1 Credit(s)™. Nursing and pharmacy (ACPE) credits are provided as well.  View complete accreditation details

Available Credit

  • 1.00 Participation
  • 1.00 Nurse
  • 1.00 Pharmacist
  • 1.00 Physician

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

To complete this activity, users will need:

  • A device with an Internet connection and sound playback capability
  • Adobe Reader or other PDF reader software for certificate viewing/printing